Antiangiogenic drug to treat cancer, arthritis and retinopathy
US6849757B2 · kind B2 · utility
4Cited by
8References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2003 |
| Grant date | Feb 1, 2005 |
| Priority date | — |
| Expiry date | Jul 10, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C237/22
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds having Formula I or pharmaceutically acceptable salts or prodrugs thereof, are useful for treating pathological states which arise from or are exacerbated by angiogenesis. The invention also relates to pharmaceutical compositions comprising these compounds and to methods of inhibiting angiogenesis in a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.